Found: 19
Select item for more details and to access through your institution.
Next-generation immune checkpoint inhibitors as promising functional molecules in cancer therapeutics.
- Published in:
- Cancer & Metastasis Reviews, 2023, v. 42, n. 3, p. 597, doi. 10.1007/s10555-023-10139-6
- By:
- Publication type:
- Article
Preface.
- Published in:
- Cancer & Metastasis Reviews, 2023, v. 42, n. 3, p. 593, doi. 10.1007/s10555-023-10140-z
- By:
- Publication type:
- Article
Biographies.
- Published in:
- Cancer & Metastasis Reviews, 2023, v. 42, n. 3, p. 591, doi. 10.1007/s10555-023-10133-y
- Publication type:
- Article
Metabolic factors associated with the prognosis of oligometastatic patients treated with stereotactic body radiotherapy.
- Published in:
- Cancer & Metastasis Reviews, 2023, v. 42, n. 3, p. 927, doi. 10.1007/s10555-023-10110-5
- By:
- Publication type:
- Article
New progress of tuberculosis scar carcinoma.
- Published in:
- Cancer & Metastasis Reviews, 2023, v. 42, n. 3, p. 653, doi. 10.1007/s10555-023-10128-9
- By:
- Publication type:
- Article
Potent molecular-targeted therapies for gastro-entero-pancreatic neuroendocrine carcinoma.
- Published in:
- Cancer & Metastasis Reviews, 2023, v. 42, n. 3, p. 1021, doi. 10.1007/s10555-023-10121-2
- By:
- Publication type:
- Article
Current advances in nanoformulations of therapeutic agents targeting tumor microenvironment to overcome drug resistance.
- Published in:
- Cancer & Metastasis Reviews, 2023, v. 42, n. 3, p. 959, doi. 10.1007/s10555-023-10119-w
- By:
- Publication type:
- Article
Short-chain fatty acids in cancer pathogenesis.
- Published in:
- Cancer & Metastasis Reviews, 2023, v. 42, n. 3, p. 677, doi. 10.1007/s10555-023-10117-y
- By:
- Publication type:
- Article
Targeting miRNA and using miRNA as potential therapeutic options to bypass resistance in pancreatic ductal adenocarcinoma.
- Published in:
- Cancer & Metastasis Reviews, 2023, v. 42, n. 3, p. 725, doi. 10.1007/s10555-023-10127-w
- By:
- Publication type:
- Article
New insights for gynecological cancer therapies: from molecular mechanisms and clinical evidence to future directions.
- Published in:
- Cancer & Metastasis Reviews, 2023, v. 42, n. 3, p. 891, doi. 10.1007/s10555-023-10113-2
- By:
- Publication type:
- Article
Hepatocellular carcinoma: molecular mechanism, targeted therapy, and biomarkers.
- Published in:
- Cancer & Metastasis Reviews, 2023, v. 42, n. 3, p. 629, doi. 10.1007/s10555-023-10084-4
- By:
- Publication type:
- Article
Potential biomarkers for immunotherapy in non-small-cell lung cancer.
- Published in:
- Cancer & Metastasis Reviews, 2023, v. 42, n. 3, p. 661, doi. 10.1007/s10555-022-10074-y
- By:
- Publication type:
- Article
Hypoxia signaling in hepatocellular carcinoma: Challenges and therapeutic opportunities.
- Published in:
- Cancer & Metastasis Reviews, 2023, v. 42, n. 3, p. 741, doi. 10.1007/s10555-022-10071-1
- By:
- Publication type:
- Article
Current state-of-the-art on ganglioside-mediated immune modulation in the tumor microenvironment.
- Published in:
- Cancer & Metastasis Reviews, 2023, v. 42, n. 3, p. 941, doi. 10.1007/s10555-023-10108-z
- By:
- Publication type:
- Article
Recent advances in synthetic strategies and SAR of thiazolidin-4-one containing molecules in cancer therapeutics.
- Published in:
- Cancer & Metastasis Reviews, 2023, v. 42, n. 3, p. 847, doi. 10.1007/s10555-023-10106-1
- By:
- Publication type:
- Article
Oral delivery of RNAi for cancer therapy.
- Published in:
- Cancer & Metastasis Reviews, 2023, v. 42, n. 3, p. 699, doi. 10.1007/s10555-023-10099-x
- By:
- Publication type:
- Article
Nanoparticle-mediated cancer cell therapy: basic science to clinical applications.
- Published in:
- Cancer & Metastasis Reviews, 2023, v. 42, n. 3, p. 601, doi. 10.1007/s10555-023-10086-2
- By:
- Publication type:
- Article
Tetrahydrocannabinols: potential cannabimimetic agents for cancer therapy.
- Published in:
- Cancer & Metastasis Reviews, 2023, v. 42, n. 3, p. 823, doi. 10.1007/s10555-023-10078-2
- By:
- Publication type:
- Article
Natural compounds targeting nuclear receptors for effective cancer therapy.
- Published in:
- Cancer & Metastasis Reviews, 2023, v. 42, n. 3, p. 765, doi. 10.1007/s10555-022-10068-w
- By:
- Publication type:
- Article